AlphaCore Capital’s Avanos Medical AVNS Stock Holding History

AlphaCore Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-98	Closed	-$3K	–	85
2020 Q1	$3K	Buy	+98	New	+$2.93K	﹤0.01%	275

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AlphaCore Capital's AVNS Position: Q2 2020 in Review

AlphaCore Capital sold out of Avanos Medical (AVNS) in Q2 2020, closing a stake of 98 shares — an estimated $3K sold.

AlphaCore Capital first reported a position in AVNS in Q1 2020 and held it in 1 quarter. The position peaked at $3K in Q1 2020. 277 funds tracked by Wall St. Rank hold AVNS as of Q2 2020.

AlphaCore Capital reported no remaining Avanos Medical position as of Q2 2020 after selling out during the quarter.
AlphaCore Capital sold 98 Avanos Medical shares in Q2 2020, an estimated $3K.
AlphaCore Capital first reported a position in Avanos Medical in Q1 2020 and held it in 1 quarter.
AlphaCore Capital's Avanos Medical position peaked at $3K in Q1 2020.
277 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2020.

Based on AlphaCore Capital's 13F filing for Q2 2020, filed 14 Aug 2020.